C. Lefeuvre

发表

Detection of rock bridges by infrared thermal imaging and modeling

M. Jaboyedoff, M. Derron, B. Matasci, 2019, Scientific Reports.

Lessons learnt from a nosocomial COVID-19 outbreak in a geriatric acute care ward with a high attack rate

C. Annweiler, M. Asfar, C. Lefeuvre, 2021, Maturitas.

Comparison of performance between three SARS‐CoV‐2 molecular assays (Aptima™, Laboratory Developed Test‐Fusion, and R‐GENE®) with special attention to turnaround time, a key point in laboratory management

C. Lefeuvre, F. Lunel-Fabiani, H. Le Guillou-Guillemette, 2022, Journal of medical virology.

Evaluation of the Aptima™ HBV Quant Dx assay for semi-quantitative HBV viral load from dried blood spots.

C. Lefeuvre, F. Lunel-Fabiani, H. Le Guillou-Guillemette, 2020, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Epidemiological and clinical insights from SARS-CoV-2 RT-PCR cycle amplification values

S. Alizon, S. Burrel, A. de Rougemont, 2021, medRxiv.

Fatal Myopericarditis Following an Influenza A (H3N2) Infection

S. Behillil, V. Enouf, C. Lefeuvre, 2018, The American journal of case reports.

What is the true place of the SARS‐CoV‐2 rapid point‐of‐care antigen test in the hospital setting? Lessons learned from real life

D. Savary, C. Lefeuvre, H. Le Guillou-Guillemette, 2021, Journal of medical virology.

Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021

C. Charpentier, S. Cauchemez, J. Pawlotsky, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort study

C. Charpentier, Y. Yazdanpanah, D. Costagliola, 2022, BMC Infectious Diseases.

Epidemiological and clinical insights from SARS-CoV-2 RT-PCR crossing threshold values, France, January to November 2020

S. Alizon, S. Burrel, A. de Rougemont, 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Serological diagnosis of secondary syphilis in a Rituximab‐treated patient: an emerging diagnostic challenge?

N. Dupin, C. Lefeuvre, P. Grange, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

A placebo-controlled double blind trial of hydroxychloroquine in mild-to-moderate COVID-19

M. Custaud, S. Diamantis, A. Mercat, 2020, medRxiv.

Analysis of hepatic fibrosis markers in the serum of chronic hepatitis B patients according to basal core promoter/precore mutants

C. Lefeuvre, P. Jeannin, J. Boursier, 2022, Scientific Reports.

A Pleiotropic Role of the Hepatitis B Virus Core Protein in Hepatocarcinogenesis

C. Lefeuvre, H. Le Guillou-Guillemette, A. Ducancelle, 2021, International Journal of Molecular Sciences.

Deciphering an Adenovirus F41 Outbreak in Pediatric Hematopoietic Stem Cell Transplant Recipients by Whole-Genome Sequencing

C. Lefeuvre, J. Dalle, M. Salmona, 2021, Journal of Clinical Microbiology.

Urinary HPV DNA testing as a tool for cervical cancer screening in women who are reluctant to have a Pap smear in France.

Anne-Sophie Banaszuk, C. Lefeuvre, P. Veillon, 2020, The Journal of infection.

C. Lefeuvre, L. Preisser, Y. Delneste, 2021, Frontiers in Immunology.

Study Protocol: Randomised Controlled Trial Assessing the Efficacy of Strategies Involving Self-Sampling in Cervical Cancer Screening

M. Arbyn, C. Lefeuvre, A. Ducancelle, 2022, International Journal of Public Health.

Transfusion-Transmitted Hepatitis A Virus, France, 2018

A. Roque-Afonso, C. Lefeuvre, H. Le Guillou-Guillemette, 2022, Emerging infectious diseases.

Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)

A. Kouatchet, C. Lefeuvre, F. Lunel-Fabiani, 2020, Journal of Clinical Virology.

Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial

E. Vicaut, S. Rebaudet, M. Briet, 2021, Clinical Microbiology and Infection.

A first experience of transduction for differentiated HepaRG cells using lentiviral technology

D. Durantel, C. Lefeuvre, F. Lemoine, 2019, Scientific Reports.

Practical approach to method verification in plasma and validation in cerebrospinal fluid under accreditation using a flexible scope in molecular virology: setting up the HIV, HBV and HCV Aptima™ Quant Dx assays

Alexandra Ducancelle, Caroline Lefeuvre, Adeline Pivert, 2019, Clinical chemistry and laboratory medicine.

Adenovirus F41 infection and liver cytolysis in adult hematopoietic stem cell transplant recipients

S. Thépot, J. Le Goff, C. Lefeuvre, 2023, Journal of medical virology.

Acceptability to Healthcare Professionals of Home-Based HPV Self-Sampling for Cervical Screening: A French Qualitative Study Conducted in an Area with Low Access to Health Services

C. Lefeuvre, A. Ducancelle, A. Pivert, 2023, Cancers.